English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Gastric antral vascular ectasia (GAVE) accounted for 4% of non-variceal gastrointestinal hemorrhage. Even though unclear pathogenesis, GAVE often associated with chronic renal failure, autoimmune diseases and cirrhosis. Asymptomatic lesions were reasonably not to treated. The treatment options for GAVE are non-endoscopic and endoscopic treatments. For the pharmacological treatment, some success were reported for the use of octreotide, thalidomide and tranexamic acid. While the endoscopic treatment is the mainstay for treatment of symptomatic lesions. The endoscopic ablative therapies such as argon plasma coagulation was reported with good clinical outcomes. However, these treatment options had some limitation due to the need of special equipment and multiple sessions needed to control the bleeding. We reported another treatment option using the routine-achievable instrument such as endoscopic band ligation as an initial treatment which also provided a good treatment outcome and less sessions.

Massive gastric antral vascular ectasia successfully treated by endoscopic band ligation as the initial therapy